These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 7538321)

  • 1. Progression to androgen insensitivity in a novel in vitro mouse model for prostate cancer.
    Baley PA; Yoshida K; Qian W; Sehgal I; Thompson TC
    J Steroid Biochem Mol Biol; 1995 May; 52(5):403-13. PubMed ID: 7538321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in mRNA levels for growth-related genes after transplantation into castrated hosts in oncogene-induced clonal mouse prostate carcinoma.
    Egawa S; Kadmon D; Miller GJ; Scardino PT; Thompson TC
    Mol Carcinog; 1992; 5(1):52-61. PubMed ID: 1543541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Androgen sensitivity and gene expression in ras + myc-induced mouse prostate carcinomas.
    Thompson TC; Egawa S; Kadmon D; Miller GJ; Timme TL; Scardino PT; Park SH
    J Steroid Biochem Mol Biol; 1992 Sep; 43(1-3):79-85. PubMed ID: 1525069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of a panel of rat ventral prostate epithelial cell lines immortalized in the presence or absence of androgens.
    Rundlett SE; Gordon DA; Miesfeld RL
    Exp Cell Res; 1992 Nov; 203(1):214-21. PubMed ID: 1330656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA ploidy and clonal selection in ras + myc-induced mouse prostate cancer.
    Greene DR; Taylor SR; Aihara M; Yoshida K; Egawa S; Park SH; Timme TL; Yang G; Scardino PT; Thompson TC
    Int J Cancer; 1995 Jan; 60(3):395-9. PubMed ID: 7829250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1.
    Zaia A; Fraizer GC; Piantanelli L; Saunders GF
    Anticancer Res; 2001; 21(1A):1-10. PubMed ID: 11299720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased androgen receptor activity and altered c-myc expression in prostate cancer cells after long-term androgen deprivation.
    Kokontis J; Takakura K; Hay N; Liao S
    Cancer Res; 1994 Mar; 54(6):1566-73. PubMed ID: 7511045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid androgen actions on calcium signaling in rat sertoli cells and two human prostatic cell lines: similar biphasic responses between 1 picomolar and 100 nanomolar concentrations.
    Lyng FM; Jones GR; Rommerts FF
    Biol Reprod; 2000 Sep; 63(3):736-47. PubMed ID: 10952915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgen receptor stabilization in recurrent prostate cancer is associated with hypersensitivity to low androgen.
    Gregory CW; Johnson RT; Mohler JL; French FS; Wilson EM
    Cancer Res; 2001 Apr; 61(7):2892-8. PubMed ID: 11306464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgen and fibroblast growth factor (FGF) regulation of FGF receptors in S115 mouse mammary tumor cells.
    Ruohola JK; Valve EM; Vainikka S; Alitalo K; Härkönen PL
    Endocrinology; 1995 May; 136(5):2179-88. PubMed ID: 7536664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgen regulation of the messenger RNA encoding diazepam-binding inhibitor/acyl-CoA-binding protein in the human prostatic adenocarcinoma cell line LNCaP.
    Swinnen JV; Esquenet M; Heyns W; Rombauts W; Verhoeven G
    Mol Cell Endocrinol; 1994 Sep; 104(2):153-62. PubMed ID: 7527352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental oncogene induced prostate cancer.
    Thompson TC; Kadmon D; Timme TL; Merz VW; Egawa S; Krebs T; Scardino PT; Park SH
    Cancer Surv; 1991; 11():55-71. PubMed ID: 1726789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progression of androgen-sensitive mouse tumor (Shionogi carcinoma 115) to androgen-insensitive tumor after long-term removal of testosterone.
    Sato N; Watabe Y; Suzuki H; Shimazaki J
    Jpn J Cancer Res; 1993 Dec; 84(12):1300-8. PubMed ID: 8294220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suramin-induced decrease in prostate-specific antigen expression with no effect on tumor growth in the LNCaP model of human prostate cancer.
    Thalmann GN; Sikes RA; Chang SM; Johnston DA; von Eschenbach AC; Chung LW
    J Natl Cancer Inst; 1996 Jun; 88(12):794-801. PubMed ID: 8637045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth-stimulating effect of pharmacological doses of estrogen on androgen-dependent Shionogi carcinoma 115 in vivo but not in cell culture.
    Noguchi S; Nishizawa Y; Nakamura N; Uchida N; Yamaguchi K; Sato B; Kitamura Y; Matsumoto K
    Cancer Res; 1987 Jan; 47(1):263-8. PubMed ID: 3791211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progression of LNCaP prostate tumor cells during androgen deprivation: hormone-independent growth, repression of proliferation by androgen, and role for p27Kip1 in androgen-induced cell cycle arrest.
    Kokontis JM; Hay N; Liao S
    Mol Endocrinol; 1998 Jul; 12(7):941-53. PubMed ID: 9658399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of androgen receptor in the progression of human prostate tumor cells to androgen independence and insensitivity.
    Kokontis JM; Hsu S; Chuu CP; Dang M; Fukuchi J; Hiipakka RA; Liao S
    Prostate; 2005 Dec; 65(4):287-98. PubMed ID: 16015608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate cancer cells (LNCaP) generated after long-term interleukin 6 (IL-6) treatment express IL-6 and acquire an IL-6 partially resistant phenotype.
    Hobisch A; Ramoner R; Fuchs D; Godoy-Tundidor S; Bartsch G; Klocker H; Culig Z
    Clin Cancer Res; 2001 Sep; 7(9):2941-8. PubMed ID: 11555613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A model to study c-myc and v-H-ras induced prostate cancer progression in the Copenhagen rat.
    Lehr JE; Pienta KJ; Yamazaki K; Pilat MJ
    Cell Mol Biol (Noisy-le-grand); 1998 Sep; 44(6):949-59. PubMed ID: 9763199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Androgen regulation of secreted growth factors in prostate carcinoma cell and tumor lines].
    Kellner U; Wagner B; Otto U; Voigt KD; Dietel M; Knabbe C
    Verh Dtsch Ges Pathol; 1993; 77():124-8. PubMed ID: 7511269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.